Article
New Data May Push Insurers to Cover Novo, Lilly Obesity Drugs
Rating:
0.0
Views:
39
Likes:
1
Library:
1
Results of a study show Novo Nordisk's Wegovy reduced the risk of heart attack and stroke in obese and overweight patients by a greater-than-expected degree.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value